Most of the interactions that were documented with alprazolam are with medicines that modulate CYP3A4 action. Compounds that happen to be inhibitors or inducers of CYP3A would be anticipated to increase or reduce plasma alprazolam concentrations, respectively. Drug products which were examined in vivo, in conjunction with their impact on growing al